High Burden of Non-Influenza Viruses in Influenza-Like Illness in the Early Weeks of H1N1v Epidemic in France-Reference-Cited by-同舟云学术

High Burden of Non-Influenza Viruses in Influenza-Like Illness in the Early Weeks of H1N1v Epidemic in France

Published:2011-08-17 Issue:8 Volume:6 Page:e23514
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Schnepf Nathalie,Resche-Rigon Matthieu,Chaillon Antoine,Scemla Anne,Gras Guillaume,Semoun Oren,Taboulet Pierre,Molina Jean-Michel,Simon François,Goudeau Alain,LeGoff Jérôme

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Impact of the 2009 influenza A(H1N1) pandemic wave on the pattern of hibernal respiratory virus epidemics, France, 2009.;JS Casalegno;Euro Surveill,2010

2. Virtual surveillance of communicable diseases: a 20-year experience in France.;A Flahault;Stat Methods Med Res,2006

3. A new influenza surveillance system in France: the Ile-de-France “GROG”. 1. Principles and methodology.;C Hannoun;Eur J Epidemiol,1989

4. Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995.;B Lina;J Clin Microbiol,1996

5. Bulletins hebdomadaires.,2009

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Role of Viral Interference in Disrupting Biennial RSV Epidemics in Northern Stockholm;2024-08-09

2. The role of viral interference in shaping RSV epidemics following the 2009 H1N1 influenza pandemic;2024-02-27

3. International Olympic Committee (IOC) consensus statement on acute respiratory illness in athletes part 1: acute respiratory infections;British Journal of Sports Medicine;2022-07-21

4. Epidemiology and phylogenetic analysis of respiratory viruses from 2012 to 2015 – A sentinel surveillance report from union territory of Puducherry, India;Clinical Epidemiology and Global Health;2020-12

5. Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets;Expert Review of Respiratory Medicine;2020-06-04